P
Prasert Lertsanguansinchai
Researcher at King Chulalongkorn Memorial Hospital
Publications - 22
Citations - 518
Prasert Lertsanguansinchai is an academic researcher from King Chulalongkorn Memorial Hospital. The author has contributed to research in topics: Chemoradiotherapy & Radiation therapy. The author has an hindex of 10, co-authored 19 publications receiving 443 citations. Previous affiliations of Prasert Lertsanguansinchai include Chulalongkorn University.
Papers
More filters
Journal ArticleDOI
Radiation therapy in chronic hidradenitis suppurativa: case report
TL;DR: Three months follow-up showed much improvement of the lesions, and the skin was smoother without pus or odor, and radiation therapy was confirmed one treatment option for chronic hidradenitis suppurativa.
Journal Article
Pattern of local-regional recurrence in patient with early breast cancer after mastectomy: an analysis of 357 cases at King Chulalongkorn Memorial Hospital.
Prasert Lertsanguansinchai,Chawalit Lertbutsayanukul,Kris Chatamra,Kanjana Shotelersuk,Narin Voravud,Chonlakiet Khorprasert +5 more
TL;DR: Overall, chest wall and ipsilateral supraclavicular node were the most common sites of local-regional recurrence in early stage operable breast cancer who underwent mastectomy and Postoperative adjuvant radiation therapy decreased the risk of local to regional recurrence.
Journal ArticleDOI
Capecitabine (X) and radiotherapy (RT) in locally advanced squamous carcinoma of the uterine cervix: Phase II results
Efren Domingo,Vicharn Lorvidhaya,R A de los Reyes,T. Sy Ortin,Pimkhuan Kamnerdsupaphon,Chawalit Lertbutsayanukul,E. Vito-Cruz,E. Taravichitkul,N. Cupino,Prasert Lertsanguansinchai +9 more
TL;DR: The oral fluoropyrimidine X is an established and effective radiosensitizer in the treatment of uterine cervix cancer as discussed by the authors, which is the second most common female malignancy in the world.
Journal ArticleDOI
13‐cis‐Retinoic Acid and Interferon‐α2a Therapy in Locally Advanced Squamous Cell Carcinoma of the Cervix: p53 Alteration, Proliferating Cell Nuclear Antigen Expression and Angiogenesis Response*
Navapun Charuruks,Narin Voravud,Wichai Termrungruanglert,Prasert Lertsanguansinchai,Damrong Tresukosol,Somchai Niruthisard,Nakorn Sirisabya +6 more
TL;DR: To evaluate prognostic importance of p53, PCNA and vasculariza‐tion alteration in patients with locally advanced cervical squamous cell carcinoma after combination therapy with 13‐cis‐retinoic acid (13cRA) and interferon‐ α2a (IFN‐α2a).
Journal Article
Reducing radiation dose to pelvic small bowel in cervical cancer patients treated with Ir-192 intracavitary brachytherapy by using urinary bladder distension.
TL;DR: Urinary bladder distension could effectively displace pelvic small bowel and reduce the radiation dose to small bowel from Ir-192 intracavitary brachytherapy in cervical cancer patients.